Search

Author/Creator Gu, Yucui

1. HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer. Issue 4 (26th February 2021)

Authors:
Zhang, Han; Wang, Jinlu; Li, Jingtong; Zhou, Xiaoping; Yin, Lei; Wang, Yiran; Gu, Yucui; Niu, Xingjian; Yang, Yue; Ji, Hongfei; Zhang, Qingyuan
Journal:
Cancer science
Issue:
Volume 112:Issue 4(2021)
Page Start:
1603
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Serum amyloid A 1 induces suppressive neutrophils through the Toll‐like receptor 2–mediated signaling pathway to promote progression of breast cancer. Issue 4 (13th February 2022)

Authors:
Niu, Xingjian; Yin, Lei; Yang, Xudong; Yang, Yue; Gu, Yucui; Sun, Yutian; Yang, Ming; Wang, Yiran; Zhang, Qingyuan; Ji, Hongfei
Journal:
Cancer science
Issue:
Volume 113:Issue 4(2022)
Page Start:
1140
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer. (21st April 2020)

Authors:
Wang, Jinlu; Ji, Hongfei; Niu, Xingjian; Yin, Lei; Wang, Yiran; Gu, Yucui; Li, Dongbo; Zhang, Han; Lu, Minghui; Zhang, Fengxia; Zhang, Qingyuan
Other Names:
Pichler Robert Academic Editor.
Journal:
Disease markers
Issue:
Volume 2020(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Issue 1 (19th December 2019)

Authors:
Li, Dongbo; Ji, Hongfei; Niu, Xingjian; Yin, Lei; Wang, Yiran; Gu, Yucui; Wang, Jinlu; Zhou, Xiaoping; Zhang, Han; Zhang, Qingyuan
Journal:
Cancer science
Issue:
Volume 111:Issue 1(2020)
Page Start:
47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗